Parcion Private Wealth LLC Has $1.57 Million Stake in SPDR S&P Biotech ETF $XBI

Parcion Private Wealth LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,854 shares of the exchange traded fund’s stock after selling 5,845 shares during the quarter. Parcion Private Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $1,567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in XBI. JPMorgan Chase & Co. lifted its holdings in shares of SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after buying an additional 2,900,633 shares during the last quarter. Assetmark Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after buying an additional 635,782 shares during the last quarter. Greenwoods Asset Management Hong Kong Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $55,613,000. Ameriprise Financial Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after buying an additional 481,408 shares during the last quarter. Finally, Meitav Investment House Ltd. lifted its holdings in shares of SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock valued at $68,156,000 after buying an additional 281,602 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $136.45 on Thursday. The firm has a market cap of $8.79 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88. SPDR S&P Biotech ETF has a 52-week low of $73.93 and a 52-week high of $137.50. The stock has a 50-day simple moving average of $125.79 and a 200-day simple moving average of $120.36.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.